These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15096088)

  • 21. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
    Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
    Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients.
    Fabrazzo M; Monteleone P; Prisco V; Perris F; Catapano F; Tortorella A; Monteleone AM; Steardo L; Maj M
    Neuropsychobiology; 2015; 72(1):29-36. PubMed ID: 26337616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P; Lindborg SR; Birkett M; Meehan K; Jones B; Alaka K; Ferchland-Howe I; Pickard A; Taylor CC; Roth J; Battaglia J; Bitter I; Chouinard G; Morris PL; Breier A
    Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatality from olanzapine induced hyperglycemia.
    Meatherall R; Younes J
    J Forensic Sci; 2002 Jul; 47(4):893-6. PubMed ID: 12137003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
    Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
    J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.
    Narula PK; Rehan HS; Unni KE; Gupta N
    Schizophr Res; 2010 May; 118(1-3):218-23. PubMed ID: 20207521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia.
    Nagamine T
    Intern Med; 2008; 47(3):181-2. PubMed ID: 18239330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine-associated pica in a schizophrenia patient.
    Huang JH; Shiah IS; Lee WK; Tzang RF; Chang KJ
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):444. PubMed ID: 20653915
    [No Abstract]   [Full Text] [Related]  

  • 32. Comments on "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine".
    Reis de Sá A; Elkis H
    Braz J Psychiatry; 2007 Mar; 29(1):90; author reply 91. PubMed ID: 17435940
    [No Abstract]   [Full Text] [Related]  

  • 33. Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice.
    Castellani LN; Peppler WT; Miotto PM; Bush N; Wright DC
    Sci Rep; 2018 Jan; 8(1):772. PubMed ID: 29335597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
    Domon SE; Webber JC
    J Child Adolesc Psychopharmacol; 2001; 11(3):285-8. PubMed ID: 11642478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia.
    Bhanji NH; Margolese HC
    Can J Psychiatry; 2004 May; 49(5):343. PubMed ID: 15198472
    [No Abstract]   [Full Text] [Related]  

  • 37. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late-onset cholestatic hepatitis induced by olanzapine in a patient with schizophrenia.
    Hung CC; Wei IH; Huang CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1574-5. PubMed ID: 19766687
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ziprasidone alternative for olanzapine-induced hyperglycemia.
    Spivak B; Alamy SS; Jarskog LF; Sheitman BB; Lieberman JA
    Am J Psychiatry; 2002 Sep; 159(9):1606. PubMed ID: 12202289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.